Andreas Halvorsen's INBX Position Overview
Andreas Halvorsen (via Viking Global Investors Lp) currently holds 1.12 M shares of Inhibrx Biosciences, Inc. (INBX) worth $106.49 M, representing 0.30% of the portfolio. First purchased in 2020-Q3, this long-term strategic position has been held for 24 quarters.
Based on 13F filings, Andreas Halvorsen has maintained a strategic position in INBX, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2022, adding 1.33 M shares. Largest reduction occurred in Q2 2024, reducing 5.36 M shares.
Analysis based on 13F filings available since 2013 Q2
Andreas Halvorsen's Inhibrx Biosciences (INBX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Inhibrx Biosciences (INBX) Trades by Andreas Halvorsen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -313,776 | Reduce 21.82% | 1.12 M | $94.75 |
| Q4 2025 | -350,000 | Reduce 19.58% | 1.44 M | $79.00 |
| Q2 2024 | -5.36 M | Reduce 75.00% | 1.79 M | $14.17 |
| Q3 2023 | +511,627 | Add 7.71% | 7.15 M | $18.35 |
| Q4 2022 | +1.33 M | Add 25.13% | 6.64 M | $24.64 |
| Q3 2020 | +5.31 M | New Buy | 5.31 M | $18.00 |
Andreas Halvorsen's Inhibrx Biosciences Investment FAQs
Andreas Halvorsen first purchased Inhibrx Biosciences, Inc. (INBX) in Q3 2020, acquiring 5,305,866 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Andreas Halvorsen has held Inhibrx Biosciences, Inc. (INBX) for 24 quarters since Q3 2020.
Andreas Halvorsen's largest addition to Inhibrx Biosciences, Inc. (INBX) was in Q3 2020, adding 5,305,866 shares worth $95.51 M.
According to the latest 13F filing for Q2 2026, Andreas Halvorsen's firm, Viking Global Investors Lp, owns 1,123,929 shares of Inhibrx Biosciences, Inc. (INBX), valued at approximately $106.49 M.
As of the Q2 2026 filing, Inhibrx Biosciences, Inc. (INBX) represents approximately 0.30% of Andreas Halvorsen's publicly disclosed stock portfolio, making it one of their key holdings.
Andreas Halvorsen's peak holding in Inhibrx Biosciences, Inc. (INBX) was 7,150,826 shares, as reported at the end of Q3 2023.